These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 6259970

  • 1. Serologic responses of pregnant thoroughbred mares to vaccination with an inactivated equine herpesvirus 1 vaccine.
    Bryans JT.
    Am J Vet Res; 1980 Nov; 41(11):1743-6. PubMed ID: 6259970
    [Abstract] [Full Text] [Related]

  • 2. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT, Allen GP.
    Dev Biol Stand; 1982 Nov; 52():493-8. PubMed ID: 6299858
    [Abstract] [Full Text] [Related]

  • 3. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA, Mock RE, Lock TF.
    Am J Vet Res; 1980 Jul; 41(7):994-6. PubMed ID: 6254412
    [Abstract] [Full Text] [Related]

  • 4. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD, Marron AE, Bass EP, Beckenhauer WH.
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [Abstract] [Full Text] [Related]

  • 5. Equine rhinopneumonitis vaccine: immunogenicity and safety in adult horses, including pregnant mares.
    Purdy CW, Ford SJ, Porter RC.
    Am J Vet Res; 1978 Mar; 39(3):377-83. PubMed ID: 205144
    [No Abstract] [Full Text] [Related]

  • 6. Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine.
    Dutta SK, Shipley WD.
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):445-8. PubMed ID: 164808
    [Abstract] [Full Text] [Related]

  • 7. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2005 May 01; 105(1-2):47-57. PubMed ID: 15797474
    [Abstract] [Full Text] [Related]

  • 8. Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine.
    Powell DG, Dwyer RM, Traub-Dargatz JL, Fulker RH, Whalen JW, Srinivasappa J, Acree WM, Chu HJ.
    J Am Vet Med Assoc; 1997 Jul 15; 211(2):193-8. PubMed ID: 9227750
    [Abstract] [Full Text] [Related]

  • 9. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH, Townsend HG, Hannant D.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):15-30. PubMed ID: 16476492
    [Abstract] [Full Text] [Related]

  • 10. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW, Porter RC, Ford SJ.
    Am J Vet Res; 1978 May 15; 39(5):745-52. PubMed ID: 215062
    [No Abstract] [Full Text] [Related]

  • 11. Safety of RhinoquinTM, rhinopneumonitis vaccine in foals and pregnant mares.
    Purdy CW.
    Vet Med Small Anim Clin; 1977 Sep 15; 72(9):1478, 1480. PubMed ID: 199978
    [No Abstract] [Full Text] [Related]

  • 12. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA, Bogdan JR, Kanara EW, Morley PS, Haines DM.
    J Am Vet Med Assoc; 1995 Mar 15; 206(6):823-32. PubMed ID: 7538990
    [Abstract] [Full Text] [Related]

  • 13. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):81-95. PubMed ID: 16549215
    [Abstract] [Full Text] [Related]

  • 14. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075
    [Abstract] [Full Text] [Related]

  • 15. Equine vaccine for West Nile virus.
    Ng T, Hathaway D, Jennings N, Champ D, Chiang YW, Chu HJ.
    Dev Biol (Basel); 2003 May 15; 114():221-7. PubMed ID: 14677692
    [Abstract] [Full Text] [Related]

  • 16. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD, Henry JN, McKnight JD.
    Can Vet J; 1979 May 15; 20(5):145-7. PubMed ID: 226261
    [Abstract] [Full Text] [Related]

  • 17. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE, Love DN, Gilkerson JR, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):41-6. PubMed ID: 16513181
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.
    Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225
    [Abstract] [Full Text] [Related]

  • 19. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA, Bates J.
    Vet Rec; 1984 Apr 14; 114(15):375-81. PubMed ID: 6328729
    [Abstract] [Full Text] [Related]

  • 20. Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares.
    Dutta SK, Campbell DL.
    Can J Comp Med; 1977 Oct 14; 41(4):404-8. PubMed ID: 200317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.